New hope to stop Depression's return

NCT ID NCT07196501

Recruiting now Disease control Sponsor: Neurocrine Biosciences Source: ClinicalTrials.gov ↗

Summary

This study is testing if an investigational medicine called NBI-1065845 can help prevent depression symptoms from returning in people with major depressive disorder. It is for adults who are already taking standard antidepressants but still have significant symptoms. The main goal is to see if adding this medicine helps people stay well longer compared to a placebo.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Neurocrine Clinical Site
RECRUITING

Oceanside, California, 92056, United States
Neurocrine Clinical Site
RECRUITING

New Haven, Connecticut, 06520, United States
Neurocrine Clinical Site
RECRUITING

Miami Gardens, Florida, 33014, United States
Neurocrine Clinical Site
RECRUITING

Orlando, Florida, 32803, United States
Neurocrine Clinical Site
RECRUITING

Palm Bay, Florida, 32905, United States
Neurocrine Clinical Site
RECRUITING

Tampa, Florida, 33629, United States
Neurocrine Clinical Site
RECRUITING

O'Fallon, Missouri, 63368, United States
Neurocrine Clinical Site
RECRUITING

Albuquerque, New Mexico, 87109, United States
Neurocrine Clinical Site
RECRUITING

Charlotte, North Carolina, 28211, United States
Neurocrine Clinical Site
RECRUITING

Edmond, Oklahoma, 73013, United States
Neurocrine Clinical Site
RECRUITING

Oklahoma City, Oklahoma, 73112, United States
Neurocrine Clinical Site
RECRUITING

Bellaire, Texas, 77401, United States
Neurocrine Clinical Site
RECRUITING

Friendswood, Texas, 77546, United States
Neurocrine Clinical Site
RECRUITING

Stafford, Texas, 77477, United States
Neurocrine Clinical Site
RECRUITING

Wichita Falls, Texas, 76309, United States
Neurocrine Clinical Site
RECRUITING

Draper, Utah, 84020, United States
Neurocrine Clinical Site
RECRUITING

Sofia, 1303, Bulgaria
Neurocrine Clinical Site
RECRUITING

Sofia, 1408, Bulgaria
Neurocrine Clinical Site
RECRUITING

Sofia, 1680, Bulgaria
Neurocrine Clinical Site
RECRUITING

North Vancouver, British Columbia, V7P 2T4, Canada
Neurocrine Clinical Site
RECRUITING

Sherbrooke, Quebec, J1L 0H8, Canada
Neurocrine Clinical Site
RECRUITING

Toronto, M5H 1A1, Canada
Neurocrine Clinical Site
RECRUITING

Tallinn, 10138, Estonia
Neurocrine Clinical Site
RECRUITING

Tallinn, 11315, Estonia
Neurocrine Clinical Site
RECRUITING

Tartu, 50417, Estonia
Neurocrine Clinical Site
RECRUITING

Rome, 168, Italy
Neurocrine Clinical Site
RECRUITING

Bialystok, 15-879, Poland
Neurocrine Clinical Site
RECRUITING

Bydgoszcz, 85-794, Poland
Neurocrine Clinical Site
RECRUITING

Gdansk, 80-283, Poland
Neurocrine Clinical Site
RECRUITING

Barcelona, 08035, Spain
Neurocrine Clinical Site
RECRUITING

Taipei, 11217, Taiwan

Conditions

Explore the condition pages connected to this study.

MAJOR DEPRESSIVE DISORDER